Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy.

Abstract

We describe the first reported case of anaerobic sepsis due to Bacteroides fragilis with simultaneous resistance to metronidazole, beta-lactams, beta lactam/beta-lactamase inhibitors, carbapenems, macrolides, and tetracyclines. Microbiological cure and clinical improvement was achieved with linezolid therapy, an agent that may be useful for the treatment of multidrug-resistant anaerobic infections.

Cite this paper

@article{Wareham2005AnaerobicSD, title={Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy.}, author={David W. Wareham and Mark Wilks and Dilruba Ahmed and Jon S. Brazier and Michael R Millar}, journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America}, year={2005}, volume={40 7}, pages={e67-8} }